InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (13 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
13
T+90 hit rate
0%
T+90 mean return
-27.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by McAnear Justin J., Chief Financial Officer. Officer active across 2 companies, notably 10x Genomics, Inc.. Cumulatively, 29 filings have been published. Split: 1 buy · 13 sells. Total volume traded: €611k. History available since 3 May 2021. The latest transaction was filed on 20 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to McAnear Justin J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations29 total
37,220 shares0Common StockSEC:0001786386-26-000006:0
2,961 shares@ US$22.52974.1% of flowClass A Common StockSEC:0001610717-24-000453:0
2,936 shares@ US$24.30364.5% of flowClass A Common StockSEC:0001610717-24-000259:0
53,312 shares0Class A Common StockSEC:0001610717-24-000184:0
1,865 shares@ US$46.34435.5% of flowClass A Common StockSEC:0001610717-24-000090:0
1,679 shares@ US$43.33674.6% of flowClass A Common StockSEC:0001610717-23-000365:0
1,678 shares@ US$45.78114.9% of flowClass A Common StockSEC:0001610717-23-000237:0
194 shares@ US$55.06950.7% of flowClass A Common StockSEC:0001610717-23-000064:0
25,991 shares0Class A Common StockSEC:0001140361-23-013504:0
1,245 shares@ US$47.75333.8% of flowClass A Common StockSEC:0001567619-23-003782:0
686 shares@ US$34.06511.6% of flowClass A Common StockSEC:0001567619-22-020869:0
20,297 shares0Class A Common StockSEC:0001567619-22-017565:0
987 shares@ US$35.19132.4% of flowClass A Common StockSEC:0001567619-22-016677:0
967 shares@ US$48.76410.0021% mcap4.5% of flowClass A Common StockSEC:0001567619-22-011713:0
158 shares@ US$40.48550.0003% mcap0.6% of flowClass A Common StockSEC:0001567619-22-011123:0
Canonical exit: 11 Aug 2022 (T+90)
21,357 shares0Class A Common StockSEC:0001567619-22-007440:0
288 shares@ US$78.59940.0010% mcap2.0% of flowClass A Common StockSEC:0001567619-22-005520:0
10,000 shares@ US$5.040.0021% mcap4.5% of flowClass A Common StockSEC:0001567619-22-000622:0
10,000 shares@ US$5.044.5% of flowClass A Common StockSEC:0001567619-21-021618:0
281 shares@ US$148.38113.7% of flowClass A Common StockSEC:0001567619-21-021189:0
10,000 shares@ US$5.044.4% of flowClass A Common StockSEC:0001567619-21-019299:0
10,000 shares@ US$5.044.4% of flowClass A Common StockSEC:0001567619-21-017949:0
10,000 shares@ US$5.044.3% of flowClass A Common StockSEC:0001209191-21-054900:0
270 shares@ US$161.84753.7% of flowClass A Common StockSEC:0001209191-21-053392:0
10,000 shares@ US$5.044.3% of flowClass A Common StockSEC:0001209191-21-049650:0
25 of 29 declarations
About McAnear Justin J.
McAnear Justin J. is Chief Financial Officer at Alamar Biosciences, Inc. and also has a role at 10x Genomics, Inc. Across 29 filings in total, the sampled recent filings span 2021-05-05 to 2026-04-20, with EUR 6,163 in buys and EUR 605,005 in sells, and the most common transaction nature is sale.
